Overview of Platelet Levels of Patients with Pulmonary Tuberculosis at Kabila Health Center

Tiara Elpiana Djafar; Yolan Dunggio; Rita Amini Warastuti

doi:10.47918/jhts.v3i2.336

Tiara Elpiana Djafar Universitas Bina Mandiri Gorontalo
Yolan Dunggio Universitas Bina Mandiri Gorontalo
Rita Amini Warastuti Universitas Bina Mandiri Gorontalo

DOI: https://doi.org/10.47918/jhts.v3i2.336

Keywords: Pulmonary TB, Mycobacterium tuberculosis, Anti Tuberculosis Drugs, Platelet Levels, Hematology Analyzer

Abstract

The purpose of this study was to determine the results of the examination of normal and abnormal levels of platelets in patients with pulmonary tuberculosis and the causative factors that influence these levels.

This research method used a descriptive quantitative approach method. The population in this study were all patients with pulmonary tuberculosis at the Kabila Health Center as many as 23 patients. The sample used was 23 respondents using the Total Sampling technique.

The results showed that the abnormal platelet levels were 14.6% and normal platelet levels were 82.6%. Patients aged 15-50 years have abnormal platelet levels (17.4%) and normal platelet levels (82.6%). Patients with an age range of >50 years had normal platelet levels (21.7%). Male patients had normal platelet levels (26.1%), while women had abnormal platelet levels (17.4%) and had normal platelet levels (56.5%). Patients weighing 30-35kg 8.7% had abnormal platelet levels, and 4.34% had normal platelet levels. At 36-45 kg of body weight, 8.7% had abnormal platelet levels and 65.2% had normal platelet levels. At 46-55 kg of body weight, 8.7% had normal platelet levels and at 56-65 kg, 4.3% had normal platelet levels. Another factor is the length of treatment. In patients with two months of treatment, 8.7% had normal platelet levels, 17.3% had abnormal platelet levels, and 74% had normal platelet levels

References

[1] Apriani. 2019. Gambaran Jumlah Trombosit Pada Pasien Tuberkulosis Paru yang Mendapat Terapi Obat Anti Tuberkulsosis di Rumah Sakit Khusus Paru Provinsi Sumatera Selatan. Palembang: Politeknik Kesehatan Jurusan Analis Kesehatan. Karya Tulis Ilmiah
[2] Astuti PR. 2018. Pengaruh Pengobatan Tuberkulosis TerhadapJumlah Trombosit Pada Pasien Tuberkulosis Paru 2 Dan 5 Bulan. Semarang: Fakultas Ilmu Keperawatan Dan Kesehatan Universitas Muhammadiyah Semarang. Karya Tulis Ilmiah
[3] Departemen Kesehatan RI. 2011. Pedoman Nasional Penanggulangan Tuberkulosis. Jakarta
[4] Dinas Kesehatan Kabupaten Bone Bolango. 2019. Cakupan Tuberkulosis Kabupaten Bone Bolango tahun 2019.
[5] Dinas Kesehatan Provinsi Gorontalo. 2018. Cakupan Tuberkulosis Provinsi Gorontalo tahun 2018.
[6] Hasan, H. 2010. Penatalaksanaan TB Paru. EGC. Jakarta
[7] Irianti T, Yasin MN, Kusumaningtyas AR. 2016. Mengenal Anti-Tuberkulsosis. Yogyakarta
[8] Kementerian Kesehatan RI. 2018. Data dan Informasi Profil Kesehatan Indonesia. Jakarta
[9] Kenedyanti E. Sulistyorini L. 2017. Analisis Mycobacterium Tuberculosis dan Kondisi Fisik Rumah dengan Kejadia Tuberkulosis Paru. Surabaya: FKM Universitas Airlangga. Jurnal Berkala Epidemiologi. Vol 5 (2).
[10] Kurniawan N, Rahmalia S, Indriati G. 2015. Faktor-Faktor Yang Mempengaruhi Keberhasilan Pengobatan Tuberkulosis Paru. Program Studi Ilmu Keperawatan Universitas Riau. Riau. Vol 2 (1)
[11] Martiasari I. 2019. Gambaran Jumlah Trombosit Metode Automatik Pada Pengguna Obat AntiTuberkulosis (OAT) Di Puskesmas Punggelan 1. Politeknik Kesehatan Kemenkes Semarang. Karya Tulis Ilmiah. Semarang
[12] Puskesmas Kabila. 2021.Cakupan Program Tuberkulosis periodeMei-April tahun 2021.
[13] Profil PuskesmasKabila. (2019). NarasiProfil Puskesmas Kabila Kab. BoneBolango Tahun 2019.
[14] Pratiwi R, T. 2020. Gambaran Komplikasi Penyakit Tuberkulosis Berdasarkan Kode International Classification Of Disease 10. Rekam Medis dan Informasi Kesehatan Sekolah Vokasi UGM. Jurnal Kesehatan Al-Irsyad. Yogyakarta.Vol 13 (2)
[15] Rampa, E. 2020. Hasil Pemeriksaan Leukosit, Trombosit dan Hemoglobin Pada Penderita Tuberkulosis yang Mengkonsumsi OAT di RSAL Dr. Soedibjo Sardadi. Jayapura. Vol 5 (2)
[16] Sadikin M. 2006. Biokimia Darah. Widya Medika Jakarta.
[17] Safithri A. 2012. Diagnosis TB Dewasa dan Anak Berdasarkan ISTC (International Standard for TB care). Universitas Muhammadiyah Malang. Malang: Vol 7 (15)
[18] Susilawati, Tri Nugraha, Sapttawati Leli, Damayanti Kusmadewi Eka, Larasati Riska. 2018. Evaluasi Metode GeneXpert MTB/RIF Dengan Sampel Raw Sputum Untuk Mendeteksi Tuberkulosis Paru. Jurnal Epidemiologi Kesehatan Indonesia. Vol 2 (1)
[19] Wahyu, 2015. Gambaran Jumlah Pemeriksaan Trombosit Dan Hematokrit Pada Penderita Tuberculosis (TBC) Dalam Proses Pengobatan (Skripsi). Unversitas Sebelas Maret. Surakarta
[20] World Health Organization 2018. Global tuberculosis report 2018. WHO:Genewa
[21] Yusuf M. Firdayanti. Salmawati. 2018. Gambaran Nilai Trombosit Pada Pasien Tuberculosis Paru yang Mendapat Paket Obat Anti Tuberkulosis (OAT) di Rumah Sakit Umum Daerah Kota Kendari Politeknik Bina Husada Kendari. Kendari.Vol 3 (1)